pathophysiology of ibd new developments - drfalkpharma.de · patients with ibd fail to show...
TRANSCRIPT
![Page 1: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/1.jpg)
Pathophysiology of IBDNew Developments
Lloyd Mayer, MDMount Sinai Medical Center
New York, NY
![Page 2: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/2.jpg)
Pathophysiology of IBDNew Developments
• Genetic factors in IBD• Environmental factors in IBD• Immunological factors in IBD
Immune response in the normal intestineDysregulated immune response in CDDysregulated immune response in UC
• Targets for biologics in IBD
![Page 3: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/3.jpg)
Genetic Factors in IBD
• Monozygotic twin concordance rates40% to 60% for CD 5% to 20% for UC
• 15-fold increased risk if first-degree relative has IBD
• Conserved pattern of disease in CD• Genome-wide screens have identified
7 loci with linkage to IBD (IBD1-7)• NOD2 (CD), OCTN1/2 (CD), IL23R
(UC and CD)Ahmad T et al. Gastroenterology. 2004;126:1533.
Halfvarson J et al. Gastroenterology. 2003;124:1767.Peeters M et al. Gastroenterology. 1996;111:597.
![Page 4: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/4.jpg)
Science 2006;314:1461-3.
![Page 5: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/5.jpg)
![Page 6: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/6.jpg)
Environmental Factors in IBD• Many distinct environmental triggers -
“barrier breakers”Cessation of cigarette smoking (UC)Bacterial and viral infectionsDrugs: NSAIDs, antibiotics
• Bacteria clearly play a role in IBDGut flora indispensable to development of animal models of IBDTreatment with metronidazole effective in fistulizing CD Patients with IBD fail to show tolerance to their own floraNo evidence that a specific infection (eg, Mycobacterium paratuberculosis) leads to the diseaseDietary contents may influence the type and function of the flora (e.g. aluminum, iron)
Blichfeldt P et al. Scand J Gastroenterol. 1978;13:123.Campieri M et al. Gut. 2001;48:132.Duchmann R, et al. Clin Exp Immunol. 1995;102:448-455. Oliva-Hemker M et al. Inflamm Bowel Dis. 2002;8:112.
Podolsky DK. Acta Gastroenterol Belg. 1997;60:163.Pullan RD et al. N Engl J Med. 1994;330:811.
Sandborn WJ et al. Ann Intern Med. 1997;126:364.Tannock G. Inflamm Bowel Dis. 2003;9:S12.
![Page 7: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/7.jpg)
No immune activation
No immune No immune activationactivation
Macrophage and TH1immune
activation
Macrophage Macrophage and THand TH11immune immune
activationactivation
No colitisNo colitis ColitisColitis
Resident bacteriaResident bacteriaResident bacteriaNo bacteriaNo bacteriaNo bacteria
Role of Commensal Enteric Bacteria in the Pathogenesis of Role of Commensal Enteric Bacteria in the Pathogenesis of Chronic Intestinal InflammationChronic Intestinal Inflammation
MiceIL-2KO (↓)
IL-10KO
TCRα KO
CD3Ε26TGMDR1KO
SAMP1/Yit (↓)CD45RBhi SCID
RatsHLA-B27 TG
IndomethacinGuinea pigsCarrageenan
Non-human primateCotton top tamarin
![Page 8: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/8.jpg)
Are there specific bacteria involved in IBD pathogenesis?
• 16S rDNA studies suggest restricted bacterial repertoire in IBD patients (~500 species in normals)
• Cbir reactive T cells can transfer IBD in mouse models
• The same bacterial species can function differently in distinct environments (? role of aluminum, iron, trace elements) - may explain differences in disease onset and severity in different institutions.
![Page 9: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/9.jpg)
“Bacterially”-Generated Phenotypes
Kim et al. Gastro. 128:891-906, 2005
IL-10-/- Commensal Bacteria Colitis
Germ FreeIL-10-/- No Colitis
E. FecalisIL-10-/- Left sidedColitis
E. coliIL-10-/- Right sidedColitis
![Page 10: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/10.jpg)
Immunological Factors in IBD: The Normal Intestine
Geared towards a non-response (tolerance) to dietary antigens and commensal flora
![Page 11: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/11.jpg)
Innate ImmunityHard-wiredImmediate
Cell bound receptorsPattern-molecular
recognitionMacrophages,
NK cells, non-prof APC
Adaptive ImmunityRequires priming
Delayedor immediate
Soluble and cellular
Antigen-specific
B & T-cells
Rethinking the mechanismsin IBD pathogenesis
![Page 12: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/12.jpg)
Innate ImmunityInitiation
AugmentationEffector cells
Adaptive ImmunityPerpetuation
Augmentation
Regulation
Rethinking the mechanismsin IBD pathogenesis
![Page 13: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/13.jpg)
Tight Junctions Regulate Epithelial Permeability
BARRIERTIGHT JUNCTION
OCCLUDINCLAUDIN
CADHERINJAM-ZO1
The permeability of tight junctions is controlled by changes in gene expression and phosphorylation of junction proteins.
TOXIC AGENTS
LUMINAL BACTERIA
![Page 14: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/14.jpg)
Hydrophobic Mucus Protects the Epithelial Cell Layer
Mucin oligosaccharides bind with ITF to form a hydrophobic lining on the luminal surface.
TOXIC AGENTSMUCINSMUC2, 3
GOBLETCELL
INTESTINAL TREFOIL FACTOR (ITF)
MECHANICAL INJURY
![Page 15: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/15.jpg)
![Page 16: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/16.jpg)
Innate Immunity: NOD2 Signaling Activates Proinflammatory Cytokines
↑NF-κB
NOD2 SENSES PEPTIDOGLYCANS (MDP)
PROINFLAMMATORY RESPONSEINTRACELLULAR
BACTERIA
![Page 17: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/17.jpg)
PanethPanethCellsCells
AntigensAntigens
NOD2NOD2
PanethPanethCellsCells
NOD2 ExpressionNOD2 ExpressionIncreased with Increased with
inflammatory mediatorsinflammatory mediators
BacteriaBacteria
Normal villi/ low NOD2
Kobayashi, KS et al. Science (2005)307:731
NOD2 Contributes toNormal Mucosal Defenses
![Page 18: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/18.jpg)
Innate Immunity: Antimicrobial Defensins
Defensins are cationic antimicrobial peptides that can be activated constitutively or in response to bacterial components.
CONSTITUTIVEDEFENSINS
HBD-1
INDUCIBLEDEFENSINSHBD-2, 3, 4
![Page 19: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/19.jpg)
St
![Page 20: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/20.jpg)
Adaptive Immunity: Hyporesponsive Antigen-Presenting Cells and Lymphocytes
DENDRITIC CELLS↓ TOLL-LIKE RECEPTORS
MACROPHAGES ↓ TOLL-LIKE RECEPTORS
LYMPHOCYTES DIFFICULT TO
ACTIVATE; UNDERGO APOPTOSIS AFTER
ACTIVATION
![Page 21: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/21.jpg)
Adaptive Immunity: Dampened Lymphocyte Response
PLASMA CELLS
JsIgATGFβ
IL10 IMMUNE EXCLUSION
BLOOD VESSELS
MAdCAM-1
α4β7INTEGRIN
LYMPHOCYTES
J
![Page 22: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/22.jpg)
Immunological Factors in IBD: Crohn’s Disease
![Page 23: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/23.jpg)
Dysregulated Immune Response in CD(Defects in innate and adaptive immunity
and barrier function)
IL-12
IFN-γ TNFMMPsIL-1IL-6PGE2LTO3
-
collagenaseelastase
BACTERIA AND BACTERIAL PRODUCTS
IgG
↓ NOD2
IL23/IL6/TGFβ
IL17
Th17
2 pathways (IL12 and IL23) can mediate inflammation
![Page 24: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/24.jpg)
Is it really a classic Th1 response?IL-23 - a pro-inflammatory cytokineIs it really a classic Th1 response?IL-23 - a pro-inflammatory cytokine
TpTp
Th1Th1 Th2Th2
Effector T Cells
+ AntigenIL-12(p40/P35)
IL-4
IFNγTNF-α
IL-4IL-5IL-10IL-13
Th17
IL-23 (p40/p19)
IL-17
CD4+CD25-
macrophage
IL-1IL-6TNF
![Page 25: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/25.jpg)
IL-12 family of cytokines
![Page 26: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/26.jpg)
p35 -/-Immunogen and
adjuvant
NormalSeverely inflamed
organs
1 week 1 week
p35 deficient mice develop severe arthritis/colitis/encephalopathyp19 and p40-/- mice are spared
p19 or p40 -/-
IL12 and IL23 deficient IL12 deficient only
![Page 27: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/27.jpg)
Dysregulated Immune Response in CDAugmentation (in white) and perpetuation (in yellow)
INFLAMMATIONFIBROSISGRANULOMAS
↑ MAdCAM-1
TNFMMPsIL-1IL-6PGE2LTO3
-
collagenaseelastase
↑ CHEMOKINESCXCL10, 9, 11CCL3
↑LYMPHOCYTE RECRUITMENTCOUPLED WITH
DEFECTS IN APOPTOSIS OF
LPLs
Lack of normal Treg number and function (not FoxP3+ Tregs)
![Page 28: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/28.jpg)
Immunological Factors in IBD: Ulcerative Colitis
![Page 29: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/29.jpg)
Dysregulated Immune Response in UC
CRYPTITIS
C'C'
COMPLEMENT ACTIVATION
IMMUNE COMPLEX
T CELLSNK T CELLS
IFN-γ
IgG
CHEMOKINES:CXCL10CXCL9
CXCL11CCL3
PMN RECRUITMENT
MAST CELL DEGRANULATION
IL-13
![Page 30: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/30.jpg)
Dysregulated Immune Response in UCAugmentation (in white) and perpetuation (in yellow)
T CELLSNK T CELLS
IL-13
IFN-γ
ULCER
MMPsIL-1IL-6PGE2LTTNF O3
-
collagenaseelastase
IL-13↑LYMPHOCYTE RECRUITMENTCOUPLED WITH
DEFECTS IN APOPTOSIS OF
LPLs
Lack of normal Treg number and function (not FoxP3+ Tregs)
![Page 31: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/31.jpg)
Are there defects in Treg cells in IBD?
![Page 32: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/32.jpg)
Normal Intestine Versus IBD Intestine
![Page 33: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/33.jpg)
IBD - Immunoregulation Transfer to immunodeficient
mice
Transfer to immunodeficient
mice
ColitisColitis
ProtectionProtection
ColitisColitis
CD45RBhi
CD45RBhi
CD45RBhiCD45RBhi
CD4+CD25+CD4+CD25+
CD4+CD25+ IL-10-/-CD4+CD25+ IL-10-/-
Powrie et al JEM 1993
CD4+CD25+ T cells
CD45RBlo
![Page 34: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/34.jpg)
Are there defects in CD4+CD25+ T cells in IBD?
• Normal to increased numbers and function of CD4+CD25+ FoxP3+ T cells in IBD mucosa
• Children with genetic deficiency of FoxP3 (IPEX) develop polyautoimmunity and occasionally autoimmune enteropathy but not colitis or ileitis
![Page 35: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/35.jpg)
• CD8+CD28- CD101+ CD103+Vβ5.1+ - TrE cells activated by epithelial cells by antigen (? bacterial lipids) presented by CD1d/gp180 complex
• TrE cells absent in IBD mucosa (Allez, Brimnes, Dotan)
Regulatory T cellsCD8+ T cells
![Page 36: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/36.jpg)
4.72±1.41%2.23±1.04% **In vivo (LPL)% VB5.1 / CD8+ LPL
4.36±2.42%1.52±1.33% *In vitro (IEC:PB T co-culture)%VB5.1 / IEC activated CD8+ T cells (CFSElo)
Normal (n=8)IBD (n=5)
Expansion of CD8+ VB5.1+ T lymphocytes in co-cultures with IECs and normal LPL
p=0.02
p=0.0018
% VB5.1 / CD8+ PBL- 0.3-0.8%
![Page 37: Pathophysiology of IBD New Developments - drfalkpharma.de · Patients with IBD fail to show tolerance to their own flora ... Campieri M et al. Gut. 2001;48:132. Duchmann R, et al](https://reader030.vdocuments.net/reader030/viewer/2022011807/5c65c43309d3f28c6e8d4b8a/html5/thumbnails/37.jpg)
Model of IBD pathogenesis
Environment
Genetics
Mucosal Inflammation
Antigen:•Appropriate•Inappropriate•Modified
Modifiers:•Smoking•Appendectomy•? Diet •Failure of normal
immunoregulation•Over/persistentstimulation•Recruitment ofunregulatable cells
•Permeability•Immunoregulation•Immune response•Colonization
Alteredbacteria
Dietmetals